Institute for Behavioral Health
Schneider Institutes for Health Policy
The Heller School for Social Policy and Management at Brandeis University
Aiming to increase recognition of the way behaviors impact health, and to work with systems and organizations to design processes and approaches that improve the overall health of the population.
CONSTANCE M. HORGAN, SC.D.
Since the Heller School began, both faculty and students have studied mental and substance use disorders. Formalized in 2003, IBH focuses on the intersection of health, behavior, and systems of care, with an emphasis on their linkages. Its underlying premise is that these systems can be better used to promote healthier lifestyles and assist individuals to engage in behaviors which lead to better health.
Our focus is broadening to include other issues that are affected by behaviors which can be targeted by interventions and have an impact on health and wellness. In addition to studying systems of care, we investigate health outcomes that are associated with behaviors, and also develop and test methods to evaluate the effects of behaviors on health.
We consider a variety of systems of care, including health care delivery, as well as criminal justice, education, social services, housing, military and the workplace.
We hope that you find this site useful as you learn more about our research staff and our activities in behavioral health.
Tom Clark, Manager of the Prescription Drug Monitoring Program's Center of Excellence Clearinghouse, provides comments and recommendations on Massachusetts' new initiative, 'ActionPlan to Address the Opioid Epidemic in the Commonwealth.'
The Bureau of Justice Assistance has partnered with Brandeis (Mary Brolin, PI) to evaluate programs implemented by the Worcester County Sheriff's Office through a newly awarded grant - Second Chance Act "Enhanced Re-entry Program to reduce the recidivism rate of offenders.
IBH & Pew Charitable Trust co-sponsor research forum on state prescription drug monitoring programs.
Dominic Hodgkin and Cindy Thomas work with researchers at Truven Health Analytics on an investigation of prospects for future emergence of new psychiatric medications. The study examines the pathway and current status of psychotropic drugs in the pipeline (pre-clinical trial to FDA approval).
Andrea Acevedo, Deborah W. Garnick, Robert Dunigan, Constance M. Horgan, Grant Ritter, Margaret T. Lee, Lee Panas, Bidorini, A., Campbell, K., Haberlin, K., Lambert-Wacey, D., Leeper, T., Reynolds, M., Wright, D. (2015). Performance measures and racial/ethnic disparities in the treatment of substance use disorders. Journal of Studies on Alcohol and Drugs. 76: 57-67. PMCID:PMC4263781
Dominic Hodgkin, Cindy P. Thomas, O'Brien PL, Levit K, Richardson J, Mark TL, et al. (2015) Projected spending on psychotropic medications 2013-2020. Administration and Policy in Mental Health. [Epub ahead of print]
Andrew Kolodny, D.T. Courtwright, C.S. Hwang, Peter Kreiner, John L. Eadie, Thomas W. Clark, G.C. Alexander. (2015) "The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health 36:559-574. DOI: 10.1146/annurev-publhealth-031914-122957
Zhu J, Weingart SN, Grant A. Ritter, Christopher P. Tompkins, Deborah W, Garnick. (2015). Racial/Ethnic disparities in patient experience with communication in hospitals: Real differences or measurement errors? Medical care. 53(5):446-454. doi: 10.1097/MLR.0000000000000350